Rosuvastatin improves myocardial function and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction and percutaneous coronary intervention / 南方医科大学学报
Journal of Southern Medical University
;
(12): 1789-1791, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-333811
ABSTRACT
<p><b>OBJECTIVE</b>To evaluate the effect of rosuvastatin on the functions of the surviving myocardium and arteriosclerosis plaque in patients with ST-segment elevation after acute myocardial infarction (STEMI) and percutaneous coronary intervention (PCI).</p><p><b>METHODS</b>Sixty-five STEMI patients were randomized to receive 40 mg simvastatin (n=32) or 10 mg rosuvastatin (n=33) before sleep in addition to conventional medications. Before PCI and after the 12-month medications, the plasma levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), C-reactive protein (CRP) and tumor necrosis factor-α (TNF-α) were measured, and echocardiography and (99)Tc(m)-MIBI single-photon emission computed tomography (SPECT) were performed to assess the therapeutic effects.</p><p><b>RESULTS</b>At the end of 12 months, the patients in simvastatin group showed significantly reduced total cholesterol, LDL-C, CRP, TNF-α, and (99)Tc(m)-MIBI uptake fraction. In rosuvastatin group, these reductions were even more obvious; the intima media thickness (IMT) of the common carotid artery was reduced significantly after a 12-month rosuvastatin therapy, but almost remained unchanged after simvastatin therapy.</p><p><b>CONCLUSION</b>Rosuvastatin therapy in addition to conventional medications can significantly reduce IMT and improve the functions of the surviving myocardium in patients with STEMI after PCI.</p>
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Patología
/
Pirimidinas
/
Sulfonamidas
/
Terapéutica
/
Enfermedad de la Arteria Coronaria
/
Angioplastia Coronaria con Balón
/
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Usos Terapéuticos
/
Quimioterapia
/
Electrocardiografía
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Anciano
/
Femenino
/
Humanos
/
Masculino
Idioma:
Chino
Revista:
Journal of Southern Medical University
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS